Blueprint Medicines Corp Quarterly Other Assets, Noncurrent in USD from Q4 2014 to Q3 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of noncurrent assets classified as other.
Summary
Blueprint Medicines Corp quarterly Other Assets, Noncurrent history and growth rate from Q4 2014 to Q3 2024.
  • Blueprint Medicines Corp Other Assets, Noncurrent for the quarter ending September 30, 2024 was $52.2M, a 76.4% increase year-over-year.
Other Assets, Noncurrent, Quarterly (USD)
Other Assets, Noncurrent, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q3 2024 $52.2M +$22.6M +76.4% Sep 30, 2024 10-Q 2024-10-30
Q2 2024 $47.7M +$15.1M +46.5% Jun 30, 2024 10-Q 2024-08-01
Q1 2024 $22.6M -$11.9M -34.5% Mar 31, 2024 10-Q 2024-05-02
Q4 2023 $30.7M +$9.06M +42% Dec 31, 2023 10-Q 2024-10-30
Q3 2023 $29.6M +$4.86M +19.7% Sep 30, 2023 10-Q 2023-10-26
Q2 2023 $32.6M +$10.5M +47.8% Jun 30, 2023 10-Q 2023-08-02
Q1 2023 $34.5M +$9.33M +37.1% Mar 31, 2023 10-Q 2023-05-04
Q4 2022 $21.6M +$6.95M +47.5% Dec 31, 2022 10-K 2024-02-15
Q3 2022 $24.7M +$10.5M +74% Sep 30, 2022 10-Q 2022-11-01
Q2 2022 $22M +$10.5M +90.6% Jun 30, 2022 10-Q 2022-08-02
Q1 2022 $25.1M +$19.8M +369% Mar 31, 2022 10-Q 2022-05-03
Q4 2021 $14.6M +$8.71M +147% Dec 31, 2021 10-K 2023-02-16
Q3 2021 $14.2M +$5.53M +63.8% Sep 30, 2021 10-Q 2021-10-28
Q2 2021 $11.6M +$3.27M +39.5% Jun 30, 2021 10-Q 2021-07-29
Q1 2021 $5.36M -$5.02M -48.4% Mar 31, 2021 10-Q 2021-04-29
Q4 2020 $5.93M -$4.3M -42% Dec 31, 2020 10-K 2022-02-17
Q3 2020 $8.67M +$2.93M +50.9% Sep 30, 2020 10-Q 2020-10-29
Q2 2020 $8.29M +$2.4M +40.8% Jun 30, 2020 10-Q 2020-07-31
Q1 2020 $10.4M +$4.54M +77.6% Mar 31, 2020 10-Q 2020-05-06
Q4 2019 $10.2M +$4.67M +84% Dec 31, 2019 10-K 2021-02-17
Q3 2019 $5.74M +$162K +2.9% Sep 30, 2019 10-Q 2019-11-05
Q2 2019 $5.89M +$989K +20.2% Jun 30, 2019 10-Q 2019-08-01
Q1 2019 $5.85M +$4.5M +336% Mar 31, 2019 10-Q 2019-05-09
Q4 2018 $5.56M +$4.24M +323% Dec 31, 2018 10-K 2020-02-13
Q3 2018 $5.58M +$3.92M +237% Sep 30, 2018 10-Q 2018-10-30
Q2 2018 $4.9M +$4.05M +475% Jun 30, 2018 10-Q 2018-08-01
Q1 2018 $1.34M -$72K -5.1% Mar 31, 2018 10-Q 2018-05-02
Q4 2017 $1.31M +$458K +53.5% Dec 31, 2017 10-K 2019-02-26
Q3 2017 $1.66M +$1.1M +197% Sep 30, 2017 10-Q 2017-10-31
Q2 2017 $852K +$283K +49.7% Jun 30, 2017 10-Q 2017-08-02
Q1 2017 $1.41M +$873K +162% Mar 31, 2017 10-Q 2017-05-03
Q4 2016 $856K +$301K +54.2% Dec 31, 2016 10-K 2018-02-21
Q3 2016 $557K -$3K -0.54% Sep 30, 2016 10-Q 2016-11-10
Q2 2016 $569K +$533K +1481% Jun 30, 2016 10-Q 2016-08-09
Q1 2016 $540K -$559K -50.9% Mar 31, 2016 10-Q 2016-05-10
Q4 2015 $555K +$456K +461% Dec 31, 2015 10-K 2017-03-09
Q3 2015 $560K Sep 30, 2015 10-Q 2015-11-09
Q2 2015 $36K Jun 30, 2015 10-Q 2015-08-10
Q1 2015 $1.1M Mar 31, 2015 10-Q 2015-06-11
Q4 2014 $99K Dec 31, 2014 10-K 2016-03-11
* An asterisk sign (*) next to the value indicates that the value is likely invalid.